174 related articles for article (PubMed ID: 21844871)
1. Endogenous knockdown of survivin improves chemotherapeutic response in ALL models.
Morrison DJ; Hogan LE; Condos G; Bhatla T; Germino N; Moskowitz NP; Lee L; Bhojwani D; Horton TM; Belitskaya-Levy I; Greenberger LM; Horak ID; Grupp SA; Teachey DT; Raetz EA; Carroll WL
Leukemia; 2012 Feb; 26(2):271-9. PubMed ID: 21844871
[TBL] [Abstract][Full Text] [Related]
2. Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia.
Park E; Gang EJ; Hsieh YT; Schaefer P; Chae S; Klemm L; Huantes S; Loh M; Conway EM; Kang ES; Hoe Koo H; Hofmann WK; Heisterkamp N; Pelus L; Keerthivasan G; Crispino J; Kahn M; Müschen M; Kim YM
Blood; 2011 Aug; 118(8):2191-9. PubMed ID: 21715311
[TBL] [Abstract][Full Text] [Related]
3. Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells.
Hossain MM; Banik NL; Ray SK
Exp Cell Res; 2012 Aug; 318(13):1597-610. PubMed ID: 22507272
[TBL] [Abstract][Full Text] [Related]
4. A phase I study of EZN-3042, a novel survivin messenger ribonucleic acid (mRNA) antagonist, administered in combination with chemotherapy in children with relapsed acute lymphoblastic leukemia (ALL): a report from the therapeutic advances in childhood leukemia and lymphoma (TACL) consortium.
Raetz EA; Morrison D; Romanos-Sirakis E; Gaynon P; Sposto R; Bhojwani D; Bostrom BC; Brown P; Eckroth E; Cassar J; Malvar J; Buchbinder A; Carroll WL
J Pediatr Hematol Oncol; 2014 Aug; 36(6):458-63. PubMed ID: 24276047
[TBL] [Abstract][Full Text] [Related]
5. Targeting survivin and p53 in pediatric acute lymphoblastic leukemia.
Tyner JW; Jemal AM; Thayer M; Druker BJ; Chang BH
Leukemia; 2012 Apr; 26(4):623-32. PubMed ID: 21960246
[TBL] [Abstract][Full Text] [Related]
6. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
7. Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies.
Shinozawa I; Inokuchi K; Wakabayashi I; Dan K
Leuk Res; 2000 Nov; 24(11):965-70. PubMed ID: 11086180
[TBL] [Abstract][Full Text] [Related]
8. Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Liu X; Gao R; Dong Y; Gao L; Zhao Y; Zhao L; Zhao X; Zhang H
BMC Cancer; 2010 Aug; 10():418. PubMed ID: 20698994
[TBL] [Abstract][Full Text] [Related]
9. siRNA-mediated inhibition of survivin gene enhances the anti-cancer effect of etoposide in U-937 acute myeloid leukemia cells.
Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Ismail P; Othman F
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):44-9. PubMed ID: 27262801
[TBL] [Abstract][Full Text] [Related]
10. Reversal of drug resistance by silencing Survivin gene expression in acute myeloid leukemia cells.
Wu YH; You Y; Chen ZC; Zou P
Acta Biochim Pol; 2008; 55(4):673-80. PubMed ID: 19093040
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the expression level of Survivin gene in different groups of B-cell acute lymphoblastic leukemia patients of Iran.
Mohammadi M; Amirmahani F; Goharrizi KJ; Pakzad R; Dolat H
Mol Biol Rep; 2019 Jun; 46(3):2679-2684. PubMed ID: 31037549
[TBL] [Abstract][Full Text] [Related]
12. siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells.
Karami H; Baradaran B; Esfahani A; Estiar MA; Naghavi-Behzad M; Sakhinia M; Sakhinia E
Asian Pac J Cancer Prev; 2013; 14(12):7719-24. PubMed ID: 24460358
[TBL] [Abstract][Full Text] [Related]
13. [Gene expression of livin and survivin in adult patients with acute lymphoblastic leukemia and its clinical significance].
Li WQ; Li XL; Wang GP; Fu B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):921-5. PubMed ID: 21867615
[TBL] [Abstract][Full Text] [Related]
14. Survivin status affects prognosis and chemosensitivity in epithelial ovarian cancer.
Chen L; Liang L; Yan X; Liu N; Gong L; Pan S; Lin F; Zhang Q; Zhao H; Zheng F
Int J Gynecol Cancer; 2013 Feb; 23(2):256-63. PubMed ID: 23358177
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of cisplatin sensitivity in lung cancer xenografts by liposome-mediated delivery of the plasmid expressing small hairpin RNA targeting Survivin.
Tian H; Liu S; Zhang J; Zhang S; Cheng L; Li C; Zhang X; Dail L; Fan P; Dai L; Yan N; Wang R; Wei Y; Deng H
J Biomed Nanotechnol; 2012 Aug; 8(4):633-41. PubMed ID: 22852473
[TBL] [Abstract][Full Text] [Related]
16. TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a.
Diakos C; Zhong S; Xiao Y; Zhou M; Vasconcelos GM; Krapf G; Yeh RF; Zheng S; Kang M; Wiencke JK; Pombo-de-Oliveira MS; Panzer-Grümayer R; Wiemels JL
Blood; 2010 Dec; 116(23):4885-93. PubMed ID: 20807887
[TBL] [Abstract][Full Text] [Related]
17. Expression of Livin, an antiapoptotic protein, is an independent favorable prognostic factor in childhood acute lymphoblastic leukemia.
Choi J; Hwang YK; Sung KW; Lee SH; Yoo KH; Jung HL; Koo HH; Kim HJ; Kang HJ; Shin HY; Ahn HS
Blood; 2007 Jan; 109(2):471-7. PubMed ID: 16990595
[TBL] [Abstract][Full Text] [Related]
18. Prodigiosin produced by Serratia marcescens inhibits expression of MMP-9 and survivin and promotes caspase-3 activation with induction of apoptosis in acute lymphoblastic leukaemia cells.
Sam MR; Ghoreishi S
J Appl Microbiol; 2018 Oct; 125(4):1017-1029. PubMed ID: 29896797
[TBL] [Abstract][Full Text] [Related]
19. Survivin and aven: two distinct antiapoptotic signals in acute leukemias.
Paydas S; Tanriverdi K; Yavuz S; Disel U; Sahin B; Burgut R
Ann Oncol; 2003 Jul; 14(7):1045-50. PubMed ID: 12853345
[TBL] [Abstract][Full Text] [Related]
20. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
Zhang K; Li Y; Liu W; Gao X; Zhang K
Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
